Bayer loses third appeals case over glyphosate weedkiller

Reuters – Bayer has lost a third appeal against U.S. court verdicts that awarded damages to customers blaming their cancers on use of its glyphosate-based weedkillers, leaving the German drugs and pesticides group to pin hopes for legal relief on the U.S. Supreme Court. On Aug. 9, a California appeals court upheld an $86 million verdict that […] Read more

Bayer’s cross symbol hangs in a terminal at Frankfurt International Airport. (Typhoonski/iStock Editorial/Getty Images)

Bayer takes major writedown, flags Roundup settlement bill

Company writes down agribusiness assets

Frankfurt | Reuters — Bayer is facing a double hit from a higher legal bill for claims relating to weedkiller Roundup as well as 9.25 billion euros (C$14.2 billion) in impairments on agriculture businesses, much of it related to its Monsanto deal. The company said the write-downs, driven by weaker demand from farmers due to […] Read more


(Bayer.com)

Bayer books second-quarter loss after settlement

Frankfurt | Reuters — German drugs and pesticides group Bayer reported a 9.5 billion-euro (C$14.86 billion) net loss for its second quarter, following a US$10.9 billion settlement of U.S. lawsuits claiming that its Roundup herbicide caused cancer. The charges stemmed mainly from agreements which attempted to wrap up legal disputes inherited with its US$63 billion […] Read more


(Leonid Eremeychuk/iStock/Getty Images)

Court blocks sales of dicamba in U.S.

Bayer says it's seeking new EPA registration for 2021

Updated — Reuters — A U.S. appeals court has blocked Bayer from selling an agricultural weed killer in the United States, the latest setback for a business already fighting an expensive legal battle over another product. A three-judge panel of the Ninth U.S. Circuit Court of Appeals ruled the U.S. Environmental Protection Agency (EPA) substantially […] Read more


(Dave Bedard photo)

Bayer reporting progress in Roundup settlement talks

Frankfurt | Reuters — Bayer said on Monday it had made progress seeking a settlement over claims its glyphosate-based Roundup herbicide causes cancer, after Bloomberg reported the company reached a verbal agreement on about 50,000 to 85,000 cases. The drugs and pesticides group is keen to draw a line under the legal dispute, which it […] Read more




(KS-potashcanada.com)

K+S cuts output on weak potash demand

Frankfurt | Reuters — German mineral miner K+S will cut production of potash fertilizers, dragging core earnings lower, as a halt imposed by China on potash imports dampens global markets. “In the current weak market environment, which is further intensified by the continuing Chinese import bans on the standard potassium chloride product, adjusting production is […] Read more

Elanco Animal Health CEO Jeff Simmons speaks during an interview at the New York Stock Exchange (NYSE) on Sept. 20, 2018. (Photo: Reuters/Brendan McDermid)

Elanco to become No. 2 in animal health with Bayer deal

Reuters — Elanco Animal Health agreed to buy Bayer’s veterinary drugs unit on Tuesday in a cash and stock deal valued at US$7.6 billion (C$10 billion), creating the second largest maker of medicines for livestock and pets and expanding Elanco’s reach online. The deal is the latest in the fast-growing animal health market, which has […] Read more